Jane Mendez

1.2k citations
21 papers · 941 indexed · h-index 12
Topics
Breast Cancer Treatment Studies (13 papers)Breast Lesions and Carcinomas (9 papers)Breast Implant and Reconstruction (5 papers)

In The Last Decade

Jane Mendez

21 papers receiving 914 citations

Peers

Jane Mendez
Comparison fields: 5 of 85
  • Oncology 534
  • Cancer Research 402
  • Molecular Biology 184
  • Surgery 169
  • Pathology and Forensic Medicine 152
Replace Maysa Abu‐Khalaf with:
Maysa Abu‐Khalaf United States
Annabel Goodwin Australia
Enrique Bargalló‐Rocha Mexico
Felipe Ades Belgium
Pamela Minicozzi Italy
Sarah S. Mougalian United States
Ian Campbell New Zealand
Patrick Whitworth United States
Nina Horowitz United States
David R. Brenin United States
Jane Mendez relative to Maysa Abu‐Khalaf United States Maysa Abu‐Khalaf's profile →
Citations per field
00.5×1.5×
Maysa Abu‐Khalaf · 1×
Citations per year

Countries citing papers authored by Jane Mendez

Since Specialization
Citations

This map shows the geographic impact of Jane Mendez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane Mendez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane Mendez more than expected).

Fields of papers citing papers by Jane Mendez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane Mendez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane Mendez. The network helps show where Jane Mendez may publish in the future.

Co-authorship network of co-authors of Jane Mendez

This figure shows the co-authorship network connecting the top 25 collaborators of Jane Mendez. A scholar is included among the top collaborators of Jane Mendez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane Mendez. Jane Mendez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 13
4 8
5 74
6 95
7 28
8 75
9 1
10 56
11 99
12 9
13 107
14 29
15 311
16 1
17 1
18 12
19 15
20 2

About Jane Mendez

Jane Mendez is a scholar working on Cancer Research, Pathology and Forensic Medicine and Oncology, having authored 21 papers that have together received 941 indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (13 papers), Breast Lesions and Carcinomas (9 papers) and Breast Implant and Reconstruction (5 papers). The work is most often cited by research in Cancer Research (402 citations), Oncology (534 citations) and Family Practice (20 citations). Jane Mendez has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Amber Guth, Nina A. Bickell, Jason Wang, Soji F. Oluwole, Henry P. Godfrey, Deborah Schrag, Karen Hiotis, Michael D. Stone, Maureen Kavanah and Carol L. Rosenberg. Their work appears in journals such as Journal of Clinical Oncology, Cancer and American Journal Of Pathology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026